Methicillin-resistant Staphylococcus aureus nasal carriage among injection drug users: Six years later

Journal of Clinical Microbiology

Volumn 46, Issue 2, 2008, Pages 477-479

  Al Rawahi, G N ^a   Schreader, A G ^a   Porter, S D ^a,b   Roscoe, D L ^a,b   Gustafson, R ^c   Bryce, E A ^a,b,d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

^c VANCOUVER COASTAL HEALTH   (Canada)

^d JPPN 1111 ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; METICILLIN; PANTON VALENTINE LEUKOCIDIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ABUSE; MECA GENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SENSITIVE STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; PVL GENE; RISK FACTOR; STAPHYLOCOCCUS AUREUS;

BACTERIAL PROTEINS; BACTERIAL TOXINS; BACTERIAL TYPING TECHNIQUES; CANADA; CARRIER STATE; DNA FINGERPRINTING; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGY, MOLECULAR; EXOTOXINS; GENOTYPE; HUMANS; LEUKOCIDINS; MALE; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; NASAL CAVITY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUBSTANCE ABUSE, INTRAVENOUS;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 38949207934     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01596-07     Document Type: Article

References (23)

1. Bannerman, T. L., G. A. Hancock, F. C. Tenover, and J. M. Miller. 1995. Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus. J. Clin. Microbiol. 33:551-555.
2. Bassetti, S., and M. Battegay. 2004. Staphylococcus aureus infections in injection drug users: risk factors and prevention strategies. Infection 32:163-169.
3. Buxton, J. June 2005. Vancouver drug use epidemiology: Vancouver site report for the Canadian Community Epidemiology Network on Drug Use (CCENDU). CCENDU Vancouver site committee, Vancouver, British Columbia, Canada. http://vancouver.ca/fourpillars/pdf/report_vancouver_2005.pdf.
4. Centers for Disease Control and Prevention. 2001. Soft tissue infections among injection drug users - San Francisco, California, 1996-2000. MMWR Morb. Mortal. Wkly. Rep. 50:381-384.
5. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement. CLSI document M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Corkill, J. E., J. J. Anson, P. Griffiths, and C. A. Hart. 2004. Detection of elements of the staphylococcal cassette chromosome (SCC) in a methicillin-susceptible (mecA gene negative) homologue of a fucidin-resistant MRSA. J. Antimicrob. Chemother. 54:229-231.
7. Daly, P., E. A. Bryce, and J. Buxton. 2002. Reply to Dr. Charlebois et al. (Clin. Infect. Dis. 2002; 34:425-33). Clin. Infect. Dis. 35:1135.
8. Deplano, A., P. T. Tassios, Y. Glupczynski, E. Godfoid, and M. J. Struelens. 2000. In vivo deletion of the methicillin-resistance mec region from the chromosome of S. aureus strains. J. Antimicrob. Chemother. 46:617-619.
9. Donnio, P.-Y., D. C. Oliveira, N. A. Faria, N. Wilhelm, A. Le Coustumier, and H. de Lencastre. 2005. Partial excision of the chromosomal cassette containing the methicillin resistance determinant results in methicillin-susceptible Staphylococcus aureus. J. Clin. Microbiol. 43:4191-4193.
10. Fiebelkorn, K. R., S. A. Crawford, M. L. McElmeel, and J. H. Jorgensen. 2003. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J. Clin. Microbiol. 41:4740-4744.
11. Gilbert, M., J. MacDonald, D. Gregson, J. Siushansian, K. Zhang, S. Elsayed, K. Laupland, T. Louie, K. Hope, M. Mulvey, J. Gillespie, D. Nielsen, V. Wheeler, M. Louie, A. Honish, G. Keays, and J. Conly. 2006. Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration. CMAJ 175:149-154.
12. Huang, H., N. M. Flynn, J. H. King, C. Monchaud, M. Morita, and S. H. Cohen. 2006. Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MSRA infections in Sacramento, California. J. Clin. Microbiol. 44:2423-2427.
13. Jansen, W. T., M. M. Beitsma, C. J. Koeman, W. J. van Wamel, J. Verhoef, and A. C. Fluit. 2006. Novel mobile variants of staphylococcal cassette chromosome mec in Staphylococcus aureus. Antimicrob. Agents Chemother. 50:2072-2078.
14. Kluytmans, J., A. van Belkum, and H. Verbrugh. 1997. Nasal carnage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin. Microbiol. Rev. 10:505-520.
15. Kourbatova, E. V., J. S. Halvosa, M. D. King, S. M. Ray, N. White, and H. M. Blumberg. 2005. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections. Am. J. Infect. Control 33:385-391.
16. Lina, G., Y. Piemont, F. Godail-Gamot, M. Bes, M. O. Peter, V. Gauduchon, F. Vandenesch, and J. Etienne. 1999. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin. Infect. Dis. 29:1128-1132.
17. McDougal, L. K., C. D. Steward, G. E. Killgore, J. M. Chaitram, S. K. McAllister, and F. C. Tenover. 2003. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J. Clin. Microbiol. 41:5113-5120.
18. Palepu, A., M. W. Tyndall, H. Leon, J. Muller, M. V. O'Shaughnessy, M. T. Schechter, and A. H. Anis. 2001. Hospital utilization and costs in a cohort of injection drug users. CMAJ 165:415-420.
19. Simor, A. E., M. Ofner-Agostini, E. Bryce, A. McGeer, S. Paton, M. R. Mulvey, and Canadian Hospital Epidemiology Committee and Canadian Nosocomial Infection Surveillance Program, Health Canada. 2002. Laboratory characterization of methicillin-resistant Staphylococcus aureus in Canadian hospitals: results of 5 years of national surveillance, 1995-1999. J. Infect. Dis. 186:652-660.
20. United Nations Office on Drugs and Crime. 2004. World drug report 2004, vol. 1. Analysis. United Nations Office on Drugs and Crime, New York, NY.
21. Vancouver Coastal Health. 18 March 2007, accession date. Infection control: annual report, fiscal year 2005-2006. Vancouver Coastal Health, Vancouver, British Columbia, Canada. http://www.vch.ca/quality/docs/ 2005_infection_control.pdf.
22. von Eiff, C., K. Becker, K. Machka, H. Stammer, G. Peters, et al. 2001. Nasal carriage as a source of Staphylococcus aureus bacteremia. N. Engl. J. Med. 344:11-16.
23. Weber, J. T. 2005. Community-associated methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 41:S269-S272.